Return
Anti–VEGF versus Laser Photocoagulation Surgery for Primary Treatment of Retinopathy of Prematurity: Neurodevelopmental Outcomes
S
R
K
M
S
J
S
M
DOI:10.1016/j.ophtha.2026.05.007.png)
Abstract
En 中文
To review the evidence on neurodevelopmental outcomes after intravitreal anti-vascular endothelial growth factor (VEGF) compared with laser photocoagulation surgery (LPC) for primary treatment of retinopathy of prematurity (ROP).
Journal
IF:
9.5
Papers:
1.3W
Citations:
4.4W
